ADORA2A and Parkinson disease: This understanding of the precise circuit targets of LS-A2AR signal as an upstream and integrated regulator of stress-induced depressive-like behavior provides the required rationale to expand the clinical translation of A2AR antagonist as a potentially effective anti-depressant, which has already been recently approved by US-FDA for the treatment of Parkinson’s disease with a notable safety profile28.